ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL1201507
CHEMBL1201507
Compound Name GLATIRAMER ACETATE
ChEMBL Synonyms COP-1 | GLATIRAMER ACETATE | COPAXONE | COPOLYMER-1
Max Phase 4 (Approved)
Trade Names COPAXONE

Sources

  • British National Formulary
  • Orange Book
  • Scientific Literature
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Molecule Features

CHEMBL1201507 compound icon
Drug Type:Polymer Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:Y Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
Unknown Not Available DailyMed PubMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
AMYOTROPHIC LATERAL SCLEROSISD000690EFO:0000253AMYOTROPHIC LATERAL SCLEROSIS2ClinicalTrials
MACULAR DEGENERATIOND008268EFO:0001365AGE-RELATED MACULAR DEGENERATION1ClinicalTrials
CROHN DISEASED003424EFO:0000384CROHN'S DISEASE2ClinicalTrials
MULTIPLE SCLEROSIS, RELAPSING-REMITTINGD020529EFO:0003929RELAPSING-REMITTING MULTIPLE SCLEROSIS3ClinicalTrials
OPTIC NEURITISD009902EFO:0007405OPTIC NEURITIS3ClinicalTrials
MULTIPLE SCLEROSISD009103EFO:0003885MULTIPLE SCLEROSIS4ClinicalTrials
RETT SYNDROMED015518Orphanet:778RETT SYNDROME2ClinicalTrials

Clinical Data

ClinicalTrials.gov GLATIRAMER ACETATE
The Cochrane Collaboration GLATIRAMER ACETATE

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Compound Cross References

ATC L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L03 - IMMUNOSTIMULANTS
L03A - IMMUNOSTIMULANTS
L03AX - Other immunostimulants
L03AX13 - glatiramer acetate

ChemSpider ChemSpider Identifier not yet assigned
DailyMed glatiramer acetate
Wikipedia Glatiramer_acetate
spacer
spacer